![[ICO]](/icons/blank.gif) | Name | Last modified | Size | Description |
|---|
|
|---|
![[PARENTDIR]](/icons/back.gif) | Parent Directory | | - | |
![[ ]](/icons/layout.gif) | 1743-422X-2-69-Chloroquine is a potent inhibitor of SARS coronavirus infection and spread-Vincent-et al (Virology Journal August 2005).pdf | 2020-05-11 03:37 | 2.4M | |
| A_Double-Inactivated_Severe_Acute_Respiratory_Syndrome_Coronavirus_Vaccine_Provides_Incomplete_Protection_in_Mice_Bolles, et_al_[Journal_of_Virology_2011]_zjv12201.pdf | 2020-01-31 17:33 | 6.8M | |
| A_SARS-like_cluster_of_circulating_bat_coronaviruses_shows_potential_for_human_emergence_(Zhengli-Shi_et_al_Nov_2015)_Nature_Medicine_article_nm.3985.pdf | 2020-10-08 13:54 | 1.0M | |
| A_guideline_to_limit_indoor_airborne_transmission_of_COVID-19_(Bazant_+_Bush)_PNAS_Apr_2021.pdf | 2021-04-26 16:04 | 1.4M | |
| A_pneumonia_outbreak_associated_with_a_new_cornavirus_of_probable_bat_origin_Zhou_et_al_s41586-020-2012-7.pdf | 2020-05-24 15:42 | 10M | |
| A_scoping_review_of_the_pathophysiology_of_COVID-19_(IJIP)_Marik_et_al_September_2021.pdf | 2021-09-30 08:21 | 1.4M | |
| Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 (Neeltje van Doremalen et al) - March 2020.pdf | 2020-03-13 10:36 | 668K | |
| American_attitudes_toward_the_Germ_Theory_of_Disease.pdf | 2021-02-15 12:00 | 1.8M | |
| Analysis_of_therapeutic_targets_for_SARS-CoV-2_and_discovery_of_potential_drugs_by_computational_methods_(Wu, Canrong et al)_Feb_20201-s2.0-S2211383520302999-main.pdf | 2020-03-09 12:38 | 40M | |
| Assessing_mandatory_stay_at_home_orders_and_business_closure_effects_on_the_spread_of_Covid-19_(Bendavid_et-al).pdf | 2021-01-11 01:19 | 9.1M | |
| Assessing_the_Age_Specificity_of_Infection_Fatality_Rates_for_COVID-19_(Levin_et_al)_Oct_2020_2020.07.23.20160895v6.full.pdf | 2020-10-13 12:51 | 637K | |
| Bonavero_Reports_series_Human_Rights_and_Covid-19_No.3_2020_(May_2020).pdf | 2021-02-04 23:40 | 1.2M | |
| Brain_damage_of_patients_with_COVID-19_(NIH_article)_retrieved_Jan_26_2021.pdf | 2021-01-26 19:44 | 137K | |
| COVID-19_Autoantibodies_(McGarty_(MIT)).pdf | 2021-02-10 14:10 | 1.6M | |
| COVID-19_Data_Collection_Comorbidity_and_Federal_Law_A_Historical_Retrospective_Henry_Ealy_et_al_(IPAH_PHPI_paper_Oct_2020).pdf | 2021-06-05 13:46 | 2.3M | |
| CT_differential_diagnosis_of_COVID-19_and_non-COVID-19_in_symptomatic_suspects-a_practical_scoring_method_(Luo_et_al)_BMC_Pulmonary_Medicine_2020.pdf | 2021-04-18 11:45 | 1.8M | |
| Calcifediol_Treatment_and_COVID-19_Related_Outcomes_(Vitamin_D)_Nogues_et_al_SSRN-id3771318_Lancet_Jan_2021_.pdf | 2021-02-13 22:14 | 666K | |
| Canceling_the_Spike_Protein_Striking_Visual_Evidence_Thomas_E_Levy_MD_Orthomolecular.Org_2021-10-18.pdf | 2021-10-30 22:09 | 532K | |
| Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated- Te et al., 2012_pone.0035421.pdf | 2020-01-31 17:29 | 1.3M | |
| Characteristics_and_risk_factors_for_COVID-19_diagnosis_and_adverse_outcomes_in_Mexico-an_analysis_of_89756_laboratory–confirmed_cases-Giannouchos, 2020.06.04.pdf | 2021-04-22 13:56 | 142K | |
| China_ Vaccine Law Passed _ Global Legal Monitor.pdf | 2020-02-18 13:11 | 126K | |
| Chloroquine_and_hydroxychloroquine_as_available_weapons_to_fight_COVID-19_(Colson_et_al_Feb_2020)1-s2.0-S0924857920300820-main.pdf | 2020-03-06 14:50 | 694K | |
| Community_and_Close__Contact-Exposures_Associated_with_COVID-19_Among_Symptomatic_Adults_≥18_Years_in_11_ Outpatient_HC_Facilities_US_July_2020_(CDC_report_re_facemasks).pdf | 2020-10-13 12:54 | 2.0M | |
| Comparison_of_mortality_associated_with_respiratory_viral_infections_December_2019_March_2020_with_previous_year_in_Southeastern_France_(Giraud-Gatineau_et_al)_May_2020.pdf | 2021-02-15 11:45 | 711K | |
| Comprehensive_analysis_of_T-cell-immunodominance_and_immunoprevalence_of_SARS-CoV-2_epitopes_in_COVID-19_cases.pdf | 2021-02-09 13:54 | 9.0M | |
| Correlation_between_Non-Polio_Acute_Flaccid_Paralysis_Rates_with_Pulse_Polio_Frequency_in_India_(Dhiman et al)_Aug_2018_ijerph-15-01755.pdf | 2020-08-21 14:42 | 766K | |
| Covid-19_Mortality_A_Matter_of_Vulnerability_Among_Nations_Facing_Limited_Margins_of_Adaptation_(Quentin De Larochelambert_et_al)_Nov_2020.pdf | 2021-01-07 00:15 | 4.5M | |
| Covid-19_modelling_has_failed_Ioannidis et al (Elsevier).pdf | 2020-10-14 12:11 | 3.1M | |
| D-dimer_as_a_biomarker_for_disease_severity_and_mortality_in_COVID-19_patients - a_case_control_study_Journal_of_Intensive_Care_(Yao_et_al)_July_2020.pdf | 2021-01-15 23:38 | 2.0M | |
| Do_many_people_have_pre-existing_immunity_(Doshi)_Sep_2020_bmj.m3563.full.pdf | 2020-10-20 15:56 | 559K | |
| Docs4OpenDebate_Open_Letter.pdf | 2020-09-21 19:15 | 180K | |
| Dynamic Change of COVID-19 Seroprevalence among Asymptomatic Population in Tokyo during the Second Wave - Sawako Hibino et al (Sept 2020) 2020.09.21.20198796v1.full.pdf | 2020-09-24 11:53 | 179K | |
| ED_Date_Analysis_from_unknown_NHS_Trust_John_Dee_research_September_2021.pdf | 2021-09-30 15:50 | 246K | |
| Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis - Risch2020.pdf | 2020-08-03 13:55 | 614K | |
| Early_viral_clearance_among_Covid-19_patients_when_gargling_with_Povidone-Iodine_(Mohamed_et_al)_2020.09.07.20180448v1.full.pdf | 2020-10-26 11:56 | 203K | |
| Effect_of_calcifediol_treatment_best_available_therapy_vs_best_available_therapy_on_ICU_admission_+_mortality_among_patients_ hospitalized_for_COVID-19_A_pilot_Castillo_Oct_2020.pdf | 2020-10-08 16:22 | 1.0M | |
| Effect_of_hydroxychloroquine_with_or_without_azithromycin_on_the_mortality_of_COVID-19_patients_by_Fiolet_et_al-Sep_2020_1-s2.0-S1198743X20306017-main.pdf | 2020-10-08 17:04 | 258K | |
| Effects_of_non-pharmaceutical_interventions_on_COVID-19_(Chin-et-el)-2020.07.22.20160341v3.full.pdf | 2020-12-28 17:37 | 5.7M | |
| Elevated_Plasmin(ogen)_as_a_common_Risk_Factor_for_COVID-19_Susceptibility_Hong-Lang_et_al_physrev.00013.2020 (Physiology Journal -Mar 2020).pdf | 2020-05-24 13:54 | 869K | |
| Endothelial_cell_infection_and_endothelitis_in_Covid-19 (Lancet)_Apr_2020.pdf | 2020-05-13 18:26 | 409K | |
| Evaluating_the_effects_of_shelter-in-place_policies_during_the_COVID-19_pandemic_(Berry_et_al)_PNAS_April_13_2021.pdf | 2021-05-03 17:26 | 803K | |
| Evaluating_the_number_of_unvaccinated_people_needed_to_exclude_to_prevent_SARS-CoV-2_transmissions_(Prosser_et_al)_December_2021-2021.12.08.21267162v1.full.pdf | 2021-12-12 15:42 | 871K | |
| FLCCC_Alliance_An_overview_of_the_MATH+_and_I-MASK+_Protocols-A_Guide_to_the_Management_of_COVID-19.pdf | 2020-12-10 15:12 | 3.4M | |
![[ ]](/icons/unknown.gif) | Figure (1).ppt | 2020-10-15 13:06 | 289K | |
| Figure (2).ppt | 2020-10-15 13:06 | 393K | |
| Figure (3).ppt | 2020-10-15 13:16 | 269K | |
| Figure.ppt | 2020-10-15 13:06 | 149K | |
| First_Do_No_Harm_Us_for_Them_open_letter_to_UK_Govt_from_multiple_Health_Professionals_Nov_2020.pdf | 2020-11-08 12:29 | 234K | |
| First_case_of_postmortem_study_in_a_patient_vaccinated_against_SARS-CoV-2_(Hansen_et_al)_April_2021.pdf | 2021-06-18 15:16 | 1.9M | |
| Furin_a_potential_therapeutic_target_for_COVID-19_Canrong WU_et_al_202002.00062v1.pdf | 2020-05-24 14:17 | 2.8M | |
| Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell–cell fusion but does not affect virion entry_Follis_et_al_2006.pdf | 2020-05-24 16:00 | 721K | |
![[IMG]](/icons/image2.gif) | Hansen_paper_Figure_1_(autopsy_paper).jpg | 2021-06-18 15:10 | 273K | |
| Household_Transmission_of_SARS-CoV-2_A_Systematic_Review_and_Meta-analysis_(Madewell_et_al)_JAMA_Network_Open_2020-madewell_2020_oi_200987_1607354087.12032.pdf | 2021-02-14 00:16 | 1.4M | |
| INFERR~1.PDF | 2021-04-14 19:46 | 4.6M | |
| Identification_of_the_highly_infective_genomic_composition_of_SARS-CoV-2_RNA_(Nicola_Bidoli_Thread_Reader_App)_Sep_2021.pdf | 2021-09-20 12:01 | 971K | |
| Immunization_with_SARS_Coronavirus_Vaccines_Leads_to_Pulmonary_Immunopathology_on_Challenge_with_the_SARS_Virus_(Chien-Te Tseng et al - April 2012)(pone.0035421).pdf | 2020-02-18 13:09 | 1.3M | |
| In_Vitro_Antiviral_Activity_and_Projection_of_Optimized_Dosing_Design_of_Hydroxychloroquine_for_the_Treatment_of_Severe_Acute_Respiratory_Syndrome_Cov_2_Yao_et_al_Mar_2020.pdf | 2020-03-31 17:30 | 1.6M | |
| Infection_fatality_rate-of_Covid-19_inferred_from_seroprevalence_data_(Bulletin_of_the_WHO)_BLT.20.265892_John_P_A_Ioannidis_pub_Oct_2020.pdf | 2021-01-21 22:13 | 858K | |
| JCI_Insight_A_majority_of_uninfected_adults_show_pre-existing_antibody_reactivity_against_SARS-CoV-2_(Majdoubi_et_al)_March_2021.pdf | 2021-03-16 13:11 | 1.7M | |
| Lockdown_Efficacy_Studies_(summary_from_the_HART_Group_2021).pdf | 2021-04-16 20:42 | 74K | |
| Low-dose_Hydroxychloroquine_Therapy_and_Mortality_in_Hospitalized_Patients_with_COVID-19_(Catteau et al)_Aug_2020_1-s2.0-S0924857920303423-main.pdf | 2020-08-27 10:27 | 1.1M | |
| MIT_infiltration_paper_2101.07993.pdf | 2021-05-11 08:10 | 23M | |
| MSH3_Homology_and_Potential_Recombination_Link_to_SARS-CoV-2_Furin_Cleavage_Site_(Frontiers_in_Virology)_Ambati_et_al_February_2022.pdf | 2022-02-25 15:23 | 564K | |
| Minimal_transmission_of_SARS-CoV-2_from_paediatric_COVID-19_cases_in_primary_schools_Norway-Brandal_et_al_eurosurv-26-1-1.pdf | 2021-01-31 11:13 | 220K | |
| Mutant_Measles_morbillivirus_strain_MeVvac2-SARS2-S(H)_complete_genom - Nucleotide - NCBI.pdf | 2021-08-24 12:52 | 344K | |
| NONPHA~1.PDF | 2021-01-28 22:43 | 876K | |
| Need_for_assessing_the_inhalation_of_micro(nano)plastic_debris_shed_from_masks_respirators_and_home-made_face_coverings_during_the_COVID-19_pandemic_(Han_+_He)_July_2020.pdf | 2021-02-27 13:45 | 637K | |
| Negligible_impact_of_SARS-CoV-2_variants_on_CD4+_and_CD8+_T_cell_reactivity_in_COVID-19_exposed_donors_and_vaccinees_(Tarke_et-al)_Feb_27_2021-2021.02.27.433180v1.full.pdf | 2021-03-02 17:22 | 2.1M | |
| Neuropilin-1_facilitates_SARS-CoV-2_entry_infectivity_(Cantuti-Castelvetri_et_al)_Oct_2020_science.abd2985.full.pdf | 2020-10-25 11:38 | 2.7M | |
| New_Quality-Control_investigations_on_Vaccines-micro-and_nanocontamination-IJVV-04-00072-2017.pdf | 2021-03-03 21:10 | 1.0M | |
| No_evidence_for_increased_transmissibility_from_recurrent_mutations_in_SARS-CoV-2_(Van Dorp et al - Nov 2020).pdf | 2020-12-28 19:46 | 4.5M | |
| Nosocomial_infections_among_patients_with_COVID-19_SARS_and_MERS_a_rapid_review_and_meta-analysis_(Zhou_et_al)_April_2020-atm-08-10-629.pdf | 2021-03-02 14:49 | 2.1M | |
| Omicron_infection_enhances_neutralizing_immunity_against_the_Delta_variant_(pre-print)_MEDRXIV-2021-268439v1-Sigal_Khan_et_al_December_2021.pdf | 2021-12-28 10:42 | 450K | |
| Pathogenic_antibodies_induced_by_spike_proteins_of_COVID-19_and_SARS-CoV-2_viruses_(Wang_et_al)_June_2021.pdf | 2021-10-14 07:42 | 1.7M | |
| Pathogenic_priming_likely_contributes_to_serious_and_critical_illness_and_mortality_in_COVID-19_via_autoimmunity_Journal_of_Translational_Autoimmunity_April_2020_James_Lyons-Weiler.pdf | 2021-03-25 12:30 | 214K | |
| Phylogenetic network analysis of SARS-CoV-2 genomes_Forster et al March 30 2020_2004999117.full.pdf | 2020-04-13 03:36 | 513K | |
| Post-lockdown_SARS-CoV-2_nucleic_acid_screening_in_nearly_ten_million_residents_of_Wuhan_China_(Nature_Cao_et_al)_Nov_2020.pdf | 2020-11-25 12:27 | 1.1M | |
| Pre-existing_polymerase_specific_T_cells_expand_in_abortive_seronegative_SARS-CoV-2_infection_(Swadling_et_al)_June_2021 2021.06.26.21259239v1.full.pdf | 2021-07-02 16:50 | 7.1M | |
| Pre-existing_polymerase_specific_T_cells_expand_in_abortive_seronegative_SARS-CoV-2_infection_(Swadling_et_al)_June_2021 2021.06.26.21259239v1.full_compressed.pdf | 2021-07-02 16:56 | 2.2M | |
| Predominance_of_antibody-resistant_SARS-CoV-2_variants_in_vaccine_breakthrough_cases_from_the_San_Francisco_Bay_Area_California_(Servellita_et_al)_Aog_2021.pdf | 2021-10-04 14:36 | 942K | |
| Preventable_deaths_from_SARS-CoV-2_in_England_and_Wales_a_systematic_analysis_of_coroners_case_reports_(Swift_Heneghan_et_al)_.pdf | 2021-07-27 14:20 | 429K | |
| Prior_SARS-CoV-2_infection_is_associated_with_protection_against_symptomatic_reinfection_Hanratti_et_al_Dec_2020-PIIS0163445320307817.pdf | 2021-01-05 23:57 | 736K | |
| Prior_immunization_with_severe_acute_respiratory_syndrome_(SARS)-associated_coronavirus_(SARS-CoV)_yasui,et_al J Immunol.181_6337-48.pdf | 2020-01-31 17:36 | 1.4M | |
| Protection_and_waning_of_natural_and_hybrid_COVID-19_immunity_(Goldberg_et_al)_December_2021-2021.12.04.21267114v1.full.pdf | 2021-12-11 18:33 | 817K | |
| Public_Health_&_Medical_Professionals_for_Transparancy_vs_FDA_001-Complaint_101021.pdf | 2021-10-13 15:50 | 1.1M | |
| Public_Health_Lessons_Learned_From_Biases_in_Coronavirus_Mortality_Overestimation_Ronald_B_Brown_PhD.pdf | 2021-01-24 17:05 | 335K | |
| Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing Luca Ferretti et al 2020-science.abb6936.full.pdf | 2020-05-27 02:32 | 1.2M | |
| RNA_Recombination_In_Vivo_in_the_Absence_of_Viral_Replication_Gallei_et_al_June_2004.pdf | 2021-07-29 14:12 | 2.0M | |
| Reactivation_of_IgA_vasculitis_after_COVID-19_vaccination_(Lancet_correspondence)_2021-07-06.pdf | 2021-10-08 13:09 | 46K | |
| Reasoning_of_spike_glycoproteins_being_more_vulnerable_to_mutations_Wu_2004.pdf | 2021-10-08 11:25 | 498K | |
| Reduced_prevalence_of_SARS-CoV-2_infection_in_ABO_blood_group_O_(ASH_Journal_Blood_Advances_Oct_2020).pdf | 2020-10-15 13:11 | 644K | |
| Reduced_prevalence_supplement_advancesadv2020002657-suppl1.pdf | 2020-10-15 13:17 | 232K | |
| Request-for-Expedited-Federal-Investigation-Into-Scientific-Fraud-in-COVID-19-Public-Health-Policies_Jan_10_2021_(with_signatories).pdf | 2021-01-10 22:58 | 775K | |
| Resurgence_of_SARS-CoV-2_Infection_in_a_Highly_Vaccinated_Health_System_Workforce_Keehner_+_Horton_NEJM_correspondence_September_02_2021.pdf | 2021-09-02 17:07 | 372K | |
| Return_of_the_Coronavirus_2019-nCoV_(Gralinski_and_Menachery_Jan_2020)viruses-12-00135-v2.pdf | 2020-02-18 13:29 | 503K | |
| Revealing_the_role_of_CD4+_T_cells_in_viral_immunity_(Sant_+_McMichael_-J. Exp. Med. 2012 Vol. 209 No. 8 1391-1395)-JEM_20121517.pdf | 2020-09-23 15:35 | 1.2M | |
| Reverse-transcribed_SARS-CoV-2_RNA_can_integrate_into_the_genome_of_cultured_human_cells_and_can_be_expressed_in_patient-derived_tissues_(Zhang_et_al)_April_2021.pdf | 2021-10-07 12:22 | 922K | |
| Reverse_genetics_with_a_full-length_infectious_cDNA_of_severe_acute_respiratory_syndrome_coronavirus_(Yount_+_Baric_et_al)_2003-12995.full.pdf | 2021-04-28 16:11 | 655K | |
| Review_of_the_Emerging_Evidence_Demonstrating_the_Efficacy_of_Ivermectin_in_the_Prophylaxis_and_Treatment_of_COVID-19_Kory_et_al_Dec_08_2020.pdf | 2020-12-10 15:13 | 2.1M | |
| Risk_of_hospital_admission_with_Covid-19_among_teachers_compared_with_healthcare_workers_and_other_adults_of_working_age_in_Scotland_Fenton_et_al_BMJ_Sep_2021.pdf | 2021-09-02 13:20 | 557K | |
| Risk_of_mortality_in_patients_infected_with_SARS-CoV-2_variant_of_concern_202012_1 - matched_cohort_study_(Challen_et_al)_Feb_2021-bmj.n579.full.pdf | 2021-03-10 13:53 | 657K | |
| Robust_T cell_immunity_in_convalescent_individuals_with_asymptomatic_or_mild_Covid-19_(Sekine et al August 2020).pdf | 2020-08-16 22:44 | 8.3M | |
| SARS-CoV-2 Spike Protein Impairs Endothelial_Function_via_Downregulation_of_ACE-2_(Lei_et_al)_April_2021.pdf | 2021-05-04 20:58 | 3.0M | |
| SARS-CoV-2_RNA_reverse-transcribed_and_integrated_into_the_human_genome_Zhang_et_al_Dec_2020.pdf | 2021-02-27 17:27 | 3.7M | |
| SARS-CoV-2_SARS-CoV_MERS-CoV_viral_load_dynamics_duration_of_viral_shedding_Cevik_et_al_(Lancet_Nov_2020)_PIIS2666524720301725.pdf | 2020-11-25 12:23 | 694K | |
| SARS-CoV-2_direct_cardiac_damage_through_spike-mediated_cardiomyocyte_fusion_Schneider_et_al_2021.pdf | 2021-09-01 13:26 | 298K | |
| SARS-CoV-2_elicits_robust_adaptive_immune_responses_regardless_of_disease_severity_(Nielsen_et_al)_May_2021.pdf | 2021-06-10 12:32 | 2.3M | |
| SARS-CoV-2_infects_lung_epithelial_cells_and_induces_senescence_and_an_inflammatory_response_in_patients_with_severe_COVID-19_(Evangelou_et_al)_May_2021-2021.01.02.424917v2.full.pdf | 2021-08-17 16:57 | 5.8M | |
| SARS-CoV-2_spike_protein_S1_induces_fibrin(ogen)_resistant_to_fibrinolysis-Implications_for_microclot_formation_in_COVID-19_(Lize M. Grobbelaar_et_al)_March_2021.pdf | 2021-06-04 13:27 | 2.3M | |
| SARS-CoV-2 infection_induces_long_lived_bone_marrow_plasma_cells_in_humans_(Nature_magazine)-Taylor_et_al_May_14_2021.pdf | 2021-06-02 15:00 | 6.6M | |
![[DIR]](/icons/folder.gif) | Safaris_et_al_Stay-at-home_policy_is_a_case_of_exception_fallacy_an_internet-based_ecological_study_(Nature_magazine)_Mar_2021/ | 2021-03-14 17:19 | - | |
| Serologic_testing_of_US_ blood_donations_to_identify_SARS-CoV-2_reactive_antibodies_Basavaraju_et-al-ciaa1785_(Jan_2021).pdf | 2021-01-03 01:18 | 709K | |
| Serum_levels_of_Vitamin_C-and_Vitamin_D_in_a_cohort_of_critically_ill_COVID-19_patients_of_a_North_American_Community_Hospital_ICU_in_May_2020_Pilot_ Study_(Arvinte_et_al)_Sep_2020_1-s2.0-S2590098620300518-main.pdf | 2020-10-08 16:29 | 903K | |
| Severe_Acute_Respiratory_Syndrome_Coronavirus_Infection_Causes_Neuronal_Death_in_the_Absence_of_Encephalitis_in_Mice_Transgenic_for_Human_ACE2_(Netland et al - May 2008)_0737-08.pdf | 2020-02-25 14:31 | 1.5M | |
| Severe_COVID-19_ A_multifaceted_viral_vasculopathy_syndrome_(Magro_et_al)) - Science_Direct_Feb_2021.pdf | 2021-06-21 11:40 | 189K | |
| Single-cell_RNA_expression_profiling_of_ACE2_the_putative_receptor_of_Wuhan_2019-nCov_Zhao,Y_Zhao,Z_Wang,Y_Zhou,Y,Yu Ma,_Wei Zu [Paper - abstract 2020, Jan)_2020.01.26.919985v1.full.pdf | 2020-01-30 15:05 | 727K | |
| Smoking, vaping and hospitalization for COVID-19 - Article (Preprint v13) _ Qeios.pdf | 2020-04-10 00:55 | 3.7M | |
| Staphylococcal_Enterotoxin_B_(SEB)_as_a_Biological_Weapon_Recognition_Management_and_Surveillance_of_Staphylococcal_Enterotoxin_(Ahanotu_et_al)_Applied_Biosafety_ABSA_2006.pdf | 2021-12-11 12:55 | 132K | |
| Superantigenic_character_of_an_insert_unique_to_SARS-CoV-2_spike_supported_by_skewed_TCR_repertoire_in_patients_with_hyperinflammation_(Cheng_et_al)_May_2020-SEB_related.pdf | 2021-12-11 12:58 | 2.5M | |
| Targets_of_T_Cell_Responses_to_SARS-CoV-2_Coronavirus_in_Humans_with_COVID-19_Disease_and_Unexposed_Individuals_Grifoni_et_al_June_2020 - ScienceDirect.pdf | 2021-04-07 12:55 | 276K | |
| Temperature_and_latitude_analysis_to_predict_potential_spread_and_seasonality_for_COVID-19_(Sajadi_et_al)_Mar_2020_SSRN-id3550308.pdf | 2020-03-14 20:33 | 2.2M | |
| The_Association_of_ABO_blood_group_with_indices_of_severity_and_multiorgan_dysfunction_in_COVID-19_(ASH_Journal_Blood_Advances_Oct_2020).pdf | 2020-10-15 13:13 | 900K | |
| The_CCP's_Global_Lockdown_Fraud _ Jan, 2021 _ Medium_Open_Letter_(Hoar_Dolan_et-al).pdf | 2021-01-11 00:04 | 1.5M | |
| The_Treatment_of_Viral_Diseases-Has_the_Truth_Been_Suppressed_for_Decades_Journal_APS_Vol_25_No_3_Fall_2020_Dr.Lee_Merritt.pdf | 2021-04-08 18:56 | 58K | |
| The_possible_origins_of_2019-nCoV_coronavirus_Xiao_B_Xiao_Lei_Feb_2020.pdf | 2020-02-21 16:35 | 551K | |
| The _role_of_vitamin_D_in_the_health_of_Hispanic_adults_with_diabetes - PubMed_(Castro_+_Penckhofer - abstract).pdf | 2021-01-15 23:52 | 95K | |
| Transmission_of_SARS-CoV-2_Delta_variant_among_vaccinated_healthcare_workers_Vietnam_SSRN-id3897733_Nguyen_et_al.pdf | 2021-08-24 10:30 | 1.4M | |
| Ultrapotent_antibodies_against_diverse_and_highly_transmissable_SARS-CoV-2_variants_(Wang_et_al)_Science_abh1766_July_2021.pdf | 2021-07-13 15:31 | 12M | |
| Uncanny_similarity_of_unique_inserts_in_the_2019-nCoV_spike_protein_to_HIV-1_gp120_and_Gag_Pradhan_et_al_2020.01.30.927871v1.full.pdf | 2020-02-02 01:27 | 3.2M | |
| Upper_respiratory_tract_SARS-CoV-2_RNA_loads_in_symptomatic_and_asymptomatic_children_and_adults_(Costa_et_al)_March_2021.pdf | 2021-03-05 15:56 | 3.0M | |
| Viral_cultures_for_COVID-19_infectious_potential_assessment – a_systematic_review - Jefferson-T_et-al_Dec_2020 ciaa1764.pdf | 2020-12-07 14:26 | 1.0M | |
| Vitamin_D_status_in_hospitalized_patients_with_SARS-CoV-2_infection_(Hernandez_et_al)_Oct_2020_dgaa733.pdf | 2020-10-28 12:19 | 1.0M | |
| Was_R_less_than_1_before_the_English_lockdowns_On_modelling_mechanistic_detail_causality_and_inference_about_Covid-19_(Wood_+_Wit)_March_15_2021-2021.02.03.21251112v2.full.pdf | 2021-04-21 13:14 | 1.1M | |
| Zinc_Ionophore_activity_of_Quercetin_and_Epigallcatechin-galleate_dabbagh-bazarbachi_2014.pdf | 2020-03-31 17:34 | 5.5M | |
| [IJID]_Early_Hydroxychloroquine_but_not_Chloroquine_use_reduces_ICU_admission_in_COVID-19_patients_(Lammers_et_al)_Sep_20201-s2.0-S1201971220321755-main.pdf | 2020-10-08 16:32 | 2.9M | |
| [LANCET]_Are_patients_with_hypertension_and_diabetes_melitus_at_increased_risk_for_COVID-19_infection_(Fang_et_al)_Mar_2020_PIIS2213260020301168.pdf | 2020-03-13 17:11 | 411K | |
| [LANCET]_Clinical_features_of_patients_infected_with_2019_novel_coronavirus_in_Wuhan_China_Huang_et_al_(Jan 2020)_PIIS0140673620301835.pdf | 2020-02-01 19:52 | 1.2M | |
| [LANCET]_Country_level_analysis_of_Covid-19_measures_(Lancet)_Aug_2020_PIIS258953702030208X.pdf | 2020-10-14 12:16 | 457K | |
| [LANCET]_Nowcasting_and_forecasting_the_potential_domestic_and_international_spread_of_the_2019-nCoV_outbreak_originating_in_Wuhan_China - a_modelling_study_(Wu, Joseph T_et_al-Jan 2020)_Lancet-nCov2019-model.pdf | 2020-02-19 15:12 | 2.6M | |
| [Letter]_A_word_of_caution_in_interpreting_COVID-19_diagnostics_tests_JMV-9999-na.pdf | 2021-02-15 15:50 | 296K | |
| [Letter]_Covid-19_does_not_lead_to_a_typical_ARDS_ATS_American_Thoracic_Society_journal_(Luciano_ Gattinoni_et_al_Mar_30_2020)_rccm.202003-0817le.pdf | 2020-04-07 22:55 | 169K | |
| [Letter]_WDA_World_Doctors_Alliance_Open_Letter_Nov_2020.pdf | 2020-11-05 18:44 | 154K | |
| [PLOS_ONE]_SARS-CoV-2_positivity_rates_associated_with_circulating_25-hydroxyvitamin_D_levels_Harvey W. Kaufman_et_al_(Sep_2020]_journal.pone.0239252.pdf | 2020-10-08 15:19 | 1.3M | |
| [PUBMED]_Chloroquine_phosphate_has_shown_apparent_efficacy_in_treatment_of_COVID-19_associated_pneumonia_in_clinical_studies_Jianjun_Gao_et_al_Feb_2020_14_2020.01047.pdf | 2020-03-20 13:39 | 200K | |
| [WILEY]_Potential_Interventions_for_Novel_Coronavirus_in_China_A_Systematic_Review-(Zhang_and_Lui_Feb_2020) Wiley_article_jmv.25707.pdf | 2020-02-26 14:30 | 244K | |
| [WILEY]_The_neuroinvasive_potential_of_SARS-CoV2_may_be_at_least_partially_responsible_for_the_respiratory_failure_of_COVID-19_patients_(Li, Yanchao).pdf | 2020-03-06 15:50 | 49K | |
| manor-figure_control_spike_protein_from_salk_research_mitochondrial_fragmentation_in_vascular_cells.png | 2021-06-21 12:31 | 835K | |
| science - Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing Luca Ferretti.ppt | 2020-04-13 14:44 | 459K | |
| science_(Neuropilin-1).ppt | 2020-10-25 11:53 | 856K | |
|
|---|
.jpg){kind=link}
